Genmab | GEN - Capitaux Propres Et Réserves

Prix De L'Action
1,711.50
Variation Quotidienne
0.50 0.03%
Mensuellement
2.33%
Annuel
27.06%
Q2 Prévisions
1,628.53




Capitaux Propres Et Réserves Changement Date
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Almirall EUR 1.49B 24.03M 2025-12
Amarin USD 459.28M 387K 2025-12
Amgen USD 8.66B 961M 2025-12
argenx SE USD 6.1B 597.47M 2025-06
AstraZeneca USD 48.67B 2.78B 2025-12
Bayer EUR 25.95B 3.75B 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Demant DKK 9.84B 446M 2025-12
Exelixis USD 2.16B 619K 2025-12
Fresenius Medical Care EUR 249.82M 12.7B 2025-12
Galapagos EUR 3.24B 788.91M 2025-12
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
GN Store Nord DKK 14.88B 4.33B 2025-12
GRIFOLS EUR 5.29B 108.05M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Lonza CHF 9.13B 513M 2025-12
Merck EUR 28.59B 344M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12